“Together with Oxford University, we have taken preliminary steps in producing an Omicron variant vaccine, in case it is needed and will be informed by emerging data,” a spokesperson for the company said in a statement.The Financial Times first reported the news, citing Sandy Douglas, a research group leader at Oxford.
“Adenovirus-based vaccines could in principle be used to respond to any new variant more rapidly than some may previously have realised,” Douglas told FT. A lab-study last week found that AstraZeneca’s antibody cocktail Evusheld retained neutralising activity against the Omicron variant. Vaccine makers Pfizer/BioNTech and Moderna also previously said they were working on Omicron- specific COVID-19 vaccines.
Blah blah blah
So much money put on the vaccines, countries will have a strain.
For all those who are new to this working from home Bitcoin trading options Here's a little tip: Get a trusted Bitcoin expert and stick to him blake_scott55 Invest and play at similar times each day. Because : In times of chaos, your investment is your anchor to success
You people have time for stupid jokes 😂😂😂😂😂🤣🤣😂